| open_in_new Antithrombotic therapy in Atrial Fibrillation & valvular heart disease a joint consensus document from the EHRA and ESC WG on Thrombosis, endorsed by the ESC WG on Valvular Heart Disease, CASSA, HRS, APHRS, SA Heart Association and SOLEACE |
August 2017 |
EUROPACE |
| open_in_new 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). |
February 2019 |
EUROPACE |
| open_in_new Management of antithrombotic therapy in AF patients presenting with ACS and/or undergoing PCI: A Summary of the Joint Consensus Document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). |
August 2018 |
Eur Heart J |
| open_in_new 2018 Joint European consensus document on the management of antithrombotic therapy in AFib patients presenting with ACS and/or PCI/ a joint cons doc of the EHRA, ESC WG on Thrombosis, EAPCI, and ACCA endorsed by the HRS, APHRS, LAHRS and CASSA |
August 2018 |
EUROPACE |